Rathbones Group PLC Ionis Pharmaceuticals Inc Transaction History

Rathbones Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $295,231 - $442,952	-6,945 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $13,288 - $16,233	225 Added 3.35%	6,945 $416,000
Q2 2019 Aug 12, 2019	SELL	$62.09 - $86.14 $104,311 - $144,715	-1,680 Reduced 20.0%	6,720 $432,000
Q1 2019 May 09, 2019	BUY	$52.92 - $81.17 $444,528 - $681,828	8,400 New	8,400 $682,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

Stay updated on Rathbones Group PLC with notifications on news.